BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16533797)

  • 1. Social and behavioral aspects of child and adolescent participation in HIV vaccine trials.
    Swartz L; Kagee A; Kafaar Z; Smit J; Bhana A; Gray G; Lesch A; Lindegger G; Milford C; Richter L; Seedat S; Skhosana N; Stein DJ
    J Int Assoc Physicians AIDS Care (Chic); 2005 Dec; 4(4):89-92. PubMed ID: 16533797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adolescents and HIV vaccine trials: what are the clinical trial site issues?
    Bekker LG; Jaspan H; McIntyre J; Wood R; Gray G
    J Int Assoc Physicians AIDS Care (Chic); 2005 Dec; 4(4):93-7. PubMed ID: 16533798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual activity and contraceptive use: the components of the decisionmaking process.
    Gage AJ
    Stud Fam Plann; 1998 Jun; 29(2):154-66. PubMed ID: 9664629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stakeholder perspectives on ethical challenges in HIV vaccine trials in South Africa.
    Essack Z; Koen J; Barsdorf N; Slack C; Quayle M; Milford C; Lindegger G; Ranchod C; Mukuka R
    Dev World Bioeth; 2010 Apr; 10(1):11-21. PubMed ID: 19459900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV vaccine trials: reconsidering the therapeutic misconception and the question of what constitutes trial related injuries.
    Schüklenk U; Ashcroft R
    Dev World Bioeth; 2007 Dec; 7(3):ii-iv. PubMed ID: 18021115
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of sexual abuse on HIV-related attitudes and behaviors in adolescent psychiatric inpatients.
    Brown LK; Kessel SM; Lourie KJ; Ford HH; Lipsitt LP
    J Am Acad Child Adolesc Psychiatry; 1997 Mar; 36(3):316-22. PubMed ID: 9055511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why we don't need a relative risk standard for adolescent HIV vaccine trials in South Africa.
    Slack CM
    Am J Bioeth; 2011 Jun; 11(6):21-2. PubMed ID: 21678209
    [No Abstract]   [Full Text] [Related]  

  • 8. (Un)risky business: adolescents and HIV prevention trials.
    Philpott S
    Am J Bioeth; 2011 Jun; 11(6):17-9. PubMed ID: 21678207
    [No Abstract]   [Full Text] [Related]  

  • 9. South African adolescents: pathways to risky sexual behavior.
    Brook DW; Morojele NK; Zhang C; Brook JS
    AIDS Educ Prev; 2006 Jun; 18(3):259-72. PubMed ID: 16774467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparations for AIDS vaccine trials. Retention, behavior change, and HIV-seroconversion among injecting drug users (IDUs) and sexual partners of IDUs.
    Marmor M; Titus S; Wolfe H; Krasinski K; Maslansky R; Simberkoff M; Beatrice S; Nichols S; Des Jarlais DC
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S207-13. PubMed ID: 7865302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to Open Peer Commentaries on "Relative versus absolute standards for everyday risk in adolescent HIV prevention trials: expanding the debate".
    Snyder J; Miller CL; Gray G
    Am J Bioeth; 2011 Jun; 11(6):W1-3. PubMed ID: 21678202
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of HIV+ and HIV- adolescents: risk factors and psychosocial determinants.
    Hein K; Dell R; Futterman D; Rotheram-Borus MJ; Shaffer N
    Pediatrics; 1995 Jan; 95(1):96-104. PubMed ID: 7770318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-related attitudes and risk behavior of young adolescent mothers.
    Brown LK; Lourie KJ; Flanagan P; High P
    AIDS Educ Prev; 1998 Dec; 10(6):565-73. PubMed ID: 9883291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adaptation of the Health Belief Model for the prevention of HIV infection].
    van Wyk NC; Basson PM
    Curationis; 1994 Aug; 17(3):44-50. PubMed ID: 7987960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Youth risk behavior survey: Bangkok, Thailand.
    Ruangkanchanasetr S; Plitponkarnpim A; Hetrakul P; Kongsakon R
    J Adolesc Health; 2005 Mar; 36(3):227-35. PubMed ID: 15737779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Provision of HIV treatment in HIV preventive vaccine trials: a developing country perspective.
    Slack C; Stobie M; Milford C; Lindegger G; Wassenaar D; Strode A; Ijsselmuiden C
    Soc Sci Med; 2005 Mar; 60(6):1197-208. PubMed ID: 15626517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The psychosocial approach to the planning and implementation of vaccine trials for HIV infection].
    Starace F; Embrione F; Fusco ML; Cafaro L
    Ann Ist Super Sanita; 2003; 39(2):259-66. PubMed ID: 14587226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral risk in early adolescents with HIV+ mothers.
    Mellins CA; Brackis-Cott E; Dolezal C; Meyer-Bahlburg HF
    J Adolesc Health; 2005 Apr; 36(4):342-51. PubMed ID: 15780790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why don't young adults protect themselves against sexual transmission of HIV? Possible answers to a complex question.
    Keller ML
    AIDS Educ Prev; 1993; 5(3):220-33. PubMed ID: 8217474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why has HIV stabilized in South Africa, yet not declined further? Age and sexual behavior patterns among youth.
    Katz I; Low-Beer D
    Sex Transm Dis; 2008 Oct; 35(10):837-42. PubMed ID: 18607312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.